Company intelligence / Profile preview

Opus Regulatory

Cambridge, Massachusetts, United Statesopusregulatory.com ↗

Ownership: Private
Development stage: Other

Overview

Opus Regulatory provides regulatory affairs consulting services to biopharmaceutical companies across all stages of development. It specializes in regulatory strategy, CMC (Chemistry, Manufacturing and Controls), labeling, and advertising/promotion support for clients ranging from early-stage biotech to large pharmaceutical firms. The team consists of highly experienced consultants with an average tenure of 17 years in the industry[1][4].

The company does not have its own clinical pipeline or products but supports client programs through expert guidance on global regulatory submissions and compliance.

Industry: Consulting

Partnerships

No major disclosed partnerships; works with a wide range of biotech and pharma clients as a service provider

Beyond the preview

Go deeper on Opus Regulatory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opus Regulatory.

Explore the full profile